RNF31

ring finger protein 31, the group of Linear ubiquitin chain assembly complex |RBR E3 ubiquitin ligases|Ring finger proteins|Zinc fingers RANBP2-type

Basic information

Region (hg38): 14:24146683-24160660

Links

ENSG00000092098NCBI:55072OMIM:612487HGNC:16031Uniprot:Q96EP0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis (Supportive), mode of inheritance: AR
  • immunodeficiency 115 with autoinflammation (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency 115 with autoinflammationARAllergy/Immunology/InfectiousThe condition involves susceptibility to infections, and and prophylactic measures, as well as early and aggressive treatment of infections with consideration of vaccine regimen, may be beneficial; For autoimmune sequelae, medical management (eg, with TNF antagonists), has been reported to be beneficialAllergy/Immunology/Infectious26008899; 30936877

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RNF31 gene.

  • not_provided (730 variants)
  • not_specified (115 variants)
  • RNF31-related_disorder (16 variants)
  • Immunodeficiency_115_with_autoinflammation (4 variants)
  • Short_stature (2 variants)
  • Polyglucosan_body_myopathy_type_1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF31 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017999.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
189
clinvar
7
clinvar
199
missense
2
clinvar
1
clinvar
384
clinvar
10
clinvar
3
clinvar
400
nonsense
6
clinvar
6
start loss
0
frameshift
6
clinvar
6
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total 2 1 401 199 10

Highest pathogenic variant AF is 0.0000020521325

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RNF31protein_codingprotein_codingENST00000324103 2113979
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000002831248050131248180.0000521
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.144936460.7640.00003896883
Missense in Polyphen122225.010.54222416
Synonymous-0.9702732531.080.00001372235
Loss of Function6.60662.20.09650.00000353618

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005840.0000584
Ashkenazi Jewish0.000.00
East Asian0.0001110.000111
Finnish0.00004640.0000464
European (Non-Finnish)0.00007100.0000706
Middle Eastern0.0001110.000111
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684). LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684). Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation (PubMed:21455173, PubMed:28189684). LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex (PubMed:20005846, PubMed:27458237). Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis (PubMed:23708998). Binds polyubiquitin of different linkage types (PubMed:23708998). {ECO:0000269|PubMed:17006537, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20005846, ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181, ECO:0000269|PubMed:22863777, ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:28189684}.;
Pathway
Necroptosis - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Signal Transduction;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Death Receptor Signalling;Regulation of TNFR1 signaling (Consensus)

Recessive Scores

pRec
0.387

Intolerance Scores

loftool
0.427
rvis_EVS
-0.57
rvis_percentile_EVS
19.01

Haploinsufficiency Scores

pHI
0.168
hipred
Y
hipred_score
0.542
ghis
0.585

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rnf31
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
protein polyubiquitination;I-kappaB kinase/NF-kappaB signaling;regulation of tumor necrosis factor-mediated signaling pathway;CD40 signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;T cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein linear polyubiquitination;positive regulation of protein targeting to mitochondrion
Cellular component
cytosol;cytoplasmic side of plasma membrane;CD40 receptor complex;LUBAC complex
Molecular function
ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase binding;ubiquitin binding;metal ion binding